Balanced news tone
News Sentiment
4519 sentiment intelligence
Chugai Pharmaceutical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
19 relevant articles
News tone and price action are not far from neutral.
90/100 classification confidence.
directly relevant articles
high-authority source matches
-3.3% over one week, +0.1% over four weeks, trend inactive, and near fair-value range.
Chugai Pharmaceutical Co Ltd (4519)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
90/100 classification
One-week reaction
-3.3%
Price reacting lower
Trend fit
Trend inactive
0.1% over four weeks
Fair value
14.0%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
1
Neutral
18
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
MSN
Direct company coverage
Chugai Pharmaceutical Co Ltd (4519)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 09:37
- Source
- MSN
TradingView
Direct company coverage
ETFs Investing in Chugai Pharmaceutical Co., Ltd. Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 19:50
- Source
- TradingView
MSN
Direct company coverage
CHUGAI PHARMACEUTICAL CO., LTD. (4519)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 06:45
- Source
- MSN
chugai-pharm.co.jp
Direct company coverage
Jun 12,2026 | Chugai Pharmaceutical × Roche Diagnostics toward deeper Co‑Creation beyond corporate boundaries
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- chugai-pharm.co.jp
Seeking Alpha
Direct company coverage
Chugai Pharmaceutical Co., Ltd. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:CHGCY) 2026-04-24
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Apr 2026 07:00
- Source
- Seeking Alpha
chugai-pharm.co.jp
Direct company coverage
Chugai Selected for the “KENKO Investment for Health” for the Third Consecutive Year
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Mar 2026 07:00
- Source
- chugai-pharm.co.jp
chugai-pharm.co.jp
Direct company coverage
Jan 29,2026 | Chugai Relocates Head Office | News | CHUGAI PHARMACEUTICAL CO., LTD.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jan 2026 08:00
- Source
- chugai-pharm.co.jp
simplywall.st
Direct company coverage
Chugai Pharmaceutical Co., Ltd. (TSE:4519) stock most popular amongst public companies who own 61%, while individual investors hold 20%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Dec 2025 08:00
- Source
- simplywall.st
Pharmaceutical Technology
Direct company coverage
Chugai to enhance kidney disease portfolio with Renalys
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Oct 2025 07:00
- Source
- Pharmaceutical Technology
citybiz
Direct company coverage
Renalys Pharma to be Acquired by Chugai Pharmaceutical
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Oct 2025 07:00
- Source
- citybiz
Market source
Direct company coverage
Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Oct 2025 07:00
- Source
- Market source
Reuters
Direct company coverage
Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 17 Oct 2025 07:00
- Source
- Reuters
Bloomberg.com
Direct company coverage
Chugai Sinks Most Since 1977 on Obesity Drug Disappointment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Aug 2025 07:00
- Source
- Bloomberg.com
The Japan Times
Direct company coverage
Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Apr 2025 07:00
- Source
- The Japan Times
chugai-pharm.co.jp
Direct company coverage
Construction of Chugai’s New Research Center “Chugai Life Science Park Yokohama” Reached Completion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Oct 2022 07:00
- Source
- chugai-pharm.co.jp
chugai-pharm.co.jp
Direct company coverage
Growth strategy “TOP I 2030” | Management Policy | Investor Relations | CHUGAI PHARMACEUTICAL CO., LTD.
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Feb 2021 09:35
- Source
- chugai-pharm.co.jp
chugai-pharm.co.jp
Direct company coverage
Sustainability Data 2025 | Data | Sustainability | CHUGAI PHARMACEUTICAL CO., LTD.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Oct 2019 02:34
- Source
- chugai-pharm.co.jp
chugai-pharm.co.jp
Direct company coverage
Strategic Alliance with Roche | Our Strategy | About Chugai | CHUGAI PHARMACEUTICAL CO., LTD.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Oct 2018 01:21
- Source
- chugai-pharm.co.jp
chugai-pharm.co.jp
Direct company coverage
Investor Relations | CHUGAI PHARMACEUTICAL CO., LTD.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2006 04:29
- Source
- chugai-pharm.co.jp